Journal of Young Pharmacists logo
Article

Guillain-Barré Syndrome Post COVID-19 Infection: A Case Report

1, 1★, 1, 1★ Corresponding author

  1. 1Department of Pharmacy Practice, KLE College of Pharmacy (A Constituent Unit of KLE Academy of Higher Education and Research, Belagavi), Vidyanagar, Hubballi, Karnataka, INDIA.

CORRESPONDENCE

Saurav Raj

Department of Pharmacy Practice, KLE College of Pharmacy (A Constituent Unit of KLE Academy of Higher Education and Research, Belagavi), Vidyanagar, Hubballi, Karnataka, INDIA.

dr.rajsaurav@gmail.com

Received: 07-10-2023; Revised: 18-10-2023; Accepted: 15-11-2023.

Volume 16, Issue 1 · pp. 130-133 · 2024 · DOI: 10.5530/jyp.2024.16.17

ABSTRACT

COVID-19 primarily impacts the respiratory system, with neurological manifestations often being thrombotic and affecting the nervous system. However, the specific presentation of demyelinating manifestations remains less clearly defined. While recent research has established a connection between COVID-19 and Guillain-Barré syndrome-a complex neurological disorder characterised by acute or chronic degeneration-the extent of this association and the distinctive features of GBS within this context remain uncertain. In this report, we present the case of acute GBS suspected to be induced by a COVID-19 infection. Notably, this patient did not exhibit any preceding respiratory, gastrointestinal, or systemic illnesses. Consequently, this case underlines the critical importance of acknowledging the potential risk of Guillain-Barré Syndrome following a COVID-19 infection, making a significant contribution to raising awareness about this potential association.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Hegde, M., Raj, S., Tikadar, D., & Nyamagoud, S. B. (2024). Guillain-Barré Syndrome Post COVID-19 Infection: A Case Report. Journal of Young Pharmacists, 16(1), 130-133. https://doi.org/10.5530/jyp.2024.16.17

    Copyright and licence

    © 2024 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0